Skip to main content
Premium Trial:

Request an Annual Quote

GeneWiz Receives CLIA Certification

NEW YORK (GenomeWeb News) – DNA testing contract research organization GeneWiz today said that it has obtained Clinical Laboratory Improvement Amendments licensure and certificate of registration from New Jersey, allowing it to offer clinical genomic testing.

In addition to KRAS and EGFR tests, the company plans to continue developing CLIA-certified assays based on traditional platforms as well as new technologies, such as next-generation sequencing, it said.

GeneWiz added that it recently expanded its laboratory operations at its South Plainfield, NJ, headquarters to include a clean suite dedicated to processing clinical and preclinical samples. The laboratory will allow the company to expand its services into biologic drug and cell bank characterization testing, clinical trial investigations, and clinical diagnostic testing.

The Scan

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.

Clinical Genomic Lab Survey Looks at Workforce Needs

Investigators use a survey approach in Genetics in Medicine Open to assess technologist applications, retention, and workforce gaps at molecular genetics and clinical cytogenetics labs in the US.

Study Considers Gene Regulatory Features Available by Sequence-Based Modeling

Investigators in Genome Biology set sequence-based models against observational and perturbation assay data, finding distal enhancer models lag behind promoter predictions.

Genetic Testing Approach Explores Origins of Blastocyst Aneuploidy

Investigators in AJHG distinguish between aneuploidy events related to meiotic missegregation in haploid cells and those involving post-zygotic mitotic errors and mosaicism.